WHO to Update Diagnostic Criteria for Hyperglycemia in Pregnancy

The World Health Organization will update its diagnostic criteria and classification for hyperglycemia in pregnancy following a Guideline Development Group meeting scheduled for October 20 to 24, 2026. The upcoming revision will replace the agency's 2013 guidelines, incorporating new clinical evidence on screening and diagnosis to better manage a condition that affects 21 million births annually. For expectant mothers and healthcare providers, the update signals a move toward more standardized and accessible screening protocols globally, answering the need for clearer guidance on a metabolic issue that complicates one in six live births.[1][2]

Hyperglycemia in pregnancy encompasses pre-existing diabetes, diabetes first diagnosed during pregnancy, and gestational diabetes mellitus. Distinguishing between these classifications remains a persistent clinical challenge, particularly in regions with high rates of undiagnosed pre-existing diabetes. The condition often emerges silently, making universal screening a critical tool for maternal health. By refining the diagnostic boundaries, the new guidelines aim to help clinicians accurately identify which form of elevated blood glucose a patient is experiencing, allowing for more tailored and effective interventions.[1][4]

The stakes for accurate diagnosis are substantial, but early detection allows for highly effective management. Elevated blood glucose during pregnancy is linked to an increased risk of hypertensive disorders, stillbirth, neonatal hypoglycemia, and birth injuries such as shoulder dystocia due to fetal macrosomia. When left unmanaged, these complications can severely impact both the immediate delivery process and the long-term health trajectory of the child, underscoring the importance of catching elevated glucose levels as early as possible in the pregnancy.[1][2]

"Early identification and accurate classification of hyperglycaemia during pregnancy are therefore critical to enable appropriate care and reduce the risk of adverse outcomes," the World Health Organization stated in its announcement. This focus on early intervention is designed to reassure expectant mothers that with the right monitoring, dietary guidance, and medical adjustments, the vast majority of these pregnancies can proceed safely to a healthy delivery. The goal is not to alarm, but to equip patients and doctors with the data needed to make informed decisions.[1]

The forthcoming update builds directly on the World Health Organization's November 2025 recommendations for the care of women with diabetes during pregnancy. The new criteria aim to provide guidance applicable across diverse resource settings, addressing the disproportionate burden of diabetes in low- and middle-income countries where routine antenatal testing can be difficult to access. By creating scalable diagnostic frameworks, global health officials hope to close the care gap that currently leaves many women in resource-constrained areas without a timely diagnosis.[1]

Current diagnostic approaches have varied significantly across different global healthcare systems, often relying on oral glucose tolerance tests administered between 24 and 28 weeks of gestation. The 2013 World Health Organization guidelines recommended classifying hyperglycemia first detected during pregnancy as either diabetes mellitus in pregnancy or gestational diabetes, using specific fasting and post-load plasma glucose thresholds. The 2026 update is expected to clarify these thresholds based on the latest observational data, reducing diagnostic ambiguity for frontline clinicians.[1][4]

Clinical practices have increasingly emphasized the importance of early screening for those at higher risk, rather than strictly waiting for the third trimester. Healthcare providers, including Norton Healthcare Provider, note that women with risk factors such as a history of gestational diabetes, a high body mass index, or a family history of diabetes may require testing earlier in their pregnancies. This proactive approach allows care teams to implement dietary changes, monitor blood glucose, and introduce medical therapies well before the standard 24-to-28-week window.[3]

Postpartum follow-up remains a critical component of comprehensive maternal care, as women who develop gestational diabetes face a significantly higher risk of developing type 2 diabetes later in life. The updated World Health Organization criteria are expected to further standardize these screening and follow-up protocols, ensuring that the one in six pregnancies affected by hyperglycemia each year receive timely, appropriate, and reassuring intervention. By bridging the gap between pregnancy care and long-term metabolic health, the new guidelines will help protect maternal well-being long after the delivery room.[1][4]